Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia

Growth hormone-releasing hormone (GHRH), a hypothalamic polypeptide, acts as a potent autocrine/paracrine growth factor in many cancers. Benign prostatic hyperplasia (BPH) is a pathologic proliferation of prostatic glandular and stromal tissues; a variety of growth factors and inflammatory processes...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Rick, Ferenc G., Schally, Andrew V., Block, Norman L., Nadji, Mehrdad, Szepeshazi, Karoly, Zarandi, Marta, Vidaurre, Irving, Perez, Roberto, Halmos, Gabor, Szalontay, Luca
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: National Academy of Sciences 2011
Gaiak:
Biological Sciences
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3048153/
https://ncbi.nlm.nih.gov/pubmed/21321192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1018086108
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak